• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Centene and WellCare Announce Five Additional State Insurance Department Approvals for Pending Merger

Share:

October 29, 2019

(Centene) stock-Centene-01-company Centene Corporation sign

Centene Corporation (NYSE: CNC) (“Centene”) and WellCare Health Plans, Inc. (NYSE: WCG) (“WellCare”) today announced that the insurance departments of Arizona, Connecticut, Georgia, Ohio and Texas have now also approved Centene’s pending acquisition of WellCare, bringing the total number of states to approve the transaction to 24.

“We are making important progress in our merger process and are pleased that state insurance regulators continue to see the benefits that our combination will bring to recipients and communities,” said Michael F. Neidorff, Centene’s Chairman, President and Chief Executive Officer. “We will continue to work with the remaining state insurance regulators to demonstrate how we will provide recipients with access to affordable, high-quality services and products as well as deliver fair compensation for providers and create savings for states.”

The companies continue to expect that the transaction will be completed by the first half of 2020.

Completion of the transaction remains subject to clearance under the Hart-Scott-Rodino Act, receipt of the remaining required state regulatory approvals and other customary closing conditions.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Additional information about the transaction can be found at centene-wellcare.com.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Virtual clinical research company Thread acquired by two private equity firmsVirtual clinical research company Thread acquired by two private equity firms
  • LTS Takes Next Step in Its Growth Journey with the Acquisition of Tapemark Inc.LTS Takes Next Step in Its Growth Journey with the Acquisition of Tapemark Inc.
  • How the FDA Uses Science to Speed Medical Device InnovationHow the FDA Uses Science to Speed Medical Device Innovation
  • Changes to look out for in Medical Devices RegulationsChanges to look out for in Medical Devices Regulations
  • 180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
  • Owens & Minor Completes Sale of MoviantoOwens & Minor Completes Sale of Movianto
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business UnitNoramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • Bayer Acquires Blackford Analysis Ltd. Bolstering the Company’s Position in Digital Medical ImagingBayer Acquires Blackford Analysis Ltd. Bolstering the Company’s Position in Digital Medical Imaging

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications